PlainRecalls
FDA Drug Moderate Class II Terminated

Amikacin Sulfate Injection, USP, 500 mg/2 mL (250 mg/mL) Rx Only, Manufactured in Hungary For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-9032-01 (individual pack), NDC 0703-9032-03 (shelf-pack carton of 10 vials).

Reported: October 19, 2016 Initiated: July 29, 2016 #D-0023-2017

Product Description

Amikacin Sulfate Injection, USP, 500 mg/2 mL (250 mg/mL) Rx Only, Manufactured in Hungary For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-9032-01 (individual pack), NDC 0703-9032-03 (shelf-pack carton of 10 vials).

Reason for Recall

CGMP Deviations

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
27,547 vials
Distribution
Nationwide and Puerto Rico
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Amikacin Sulfate Injection, USP, 500 mg/2 mL (250 mg/mL) Rx Only, Manufactured in Hungary For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-9032-01 (individual pack), NDC 0703-9032-03 (shelf-pack carton of 10 vials).. Recalled by Teva Pharmaceuticals USA. Units affected: 27,547 vials.
Why was this product recalled?
CGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on October 19, 2016. Severity: Moderate. Recall number: D-0023-2017.